In the context of the known importance of each of these molecules in oncogenicity and cancer aggressiveness, we specifically chose to investigate their levels following the perturbation of the GH-GHR axis by either addition of exogenous hGH or GHRKD. The gene discussed is GH1; the disease is cancer.